SAN DIEGO, CA – September 14, 2026 – TrialWire™, the AI-powered clinical trial patient recruitment platform, today announced that CEO and Founder Susan Fitzpatrick-Napier will speak at Outsourcing in Clinical Trials West Coast in San Diego on September 15. In her session, Accelerating Trials Using Advanced Algorithms and AI Speech Agents, Fitzpatrick-Napier will show how TrialWire finds the right people through algorithms mapped directly to a study's protocol, then uses an AI speech agent to engage, screen and advance candidates in real time, so only genuinely eligible, trial-ready people reach a site's portal for follow-up.

The message to sponsors, CROs and sites is that speed and precision are not a trade-off. The biggest delays in recruitment often happen in the gap between a candidate raising their hand and someone actually speaking with them. Closing that gap without adding work for coordinators is where trials are won or lost.

Finding the right people, not just more people

TrialWire's algorithms identify people who are actively researching their condition and health options online and match them in real time to a live study. Rather than relying on static, often outdated databases, the platform engages candidates at the moment of intent and pulls approved eligibility and exclusion criteria from trial registries such as ClinicalTrials.gov.

Matched candidates are then evaluated by the platform's AI-Match screener against the study's inclusion and exclusion criteria before any referral is made. Only those who clear that bar are advanced.

The AI speech agent: closing the contact gap

The session will focus on TrialWire's AI speech agent. It gives interested candidates a natural, conversational way to answer screening questions and move forward the moment they are ready, rather than waiting days for a callback. Because it holds these first conversations promptly and consistently, the speech agent keeps motivated candidates engaged at the point where many are typically lost. It also gives coordinators a clearer picture of each person before they pick up the phone.

The result is a faster, smoother first step for patients and a shorter, better-qualified list for sites.

Why speed only counts when it reaches the site

Fitzpatrick-Napier will show that acceleration has to be measured where enrollment actually happens. When sites are flooded with poorly qualified referrals, study coordinators burn hours chasing people who were never eligible, often while juggling multiple trials alongside routine patient care. When qualified candidates wait too long for contact, their interest fades nd they may join another study. Both slow a study down.

TrialWire's approach addresses both problems at once. Algorithms and AI screening ensure that only qualified candidates are advanced, and the AI speech agent ensures they are engaged quickly. Each candidate arrives in the site's secure portal with the context coordinators need to move straight to secondary screening.

"Accelerating a trial isn't about pushing more names at a site. It's about removing the waiting and the guesswork between a patient saying 'I'm interested' and a coordinator saying 'let's book your visit.' Our algorithms find the right people, and our AI speech agent makes sure they're engaged and screened while they're still motivated. What reaches the site is a short list of people who genuinely match the protocol and are ready to move, and that's how studies enroll on schedule."
— Susan Fitzpatrick-Napier, CEO & Founder, TrialWire

Built for the people who have to act on the referral

Every referral surfaces inside TrialWire's secure portal, built on Salesforce Health Cloud with transparent role-based access so sponsors, CROs and site coordinators. Integrated communication tools help coordinators reach candidates quickly to confirm eligibility and book visits. The platform is fully HIPAA and GDPR compliant.

About TrialWire™

TrialWire™ is an AI-powered clinical trial patient recruitment platform that helps sponsors and CROs accelerate enrollment by identifying and pre-screening motivated people who are actively seeking health information online. Rather than driving volume into sites, the platform advances only highly AI-screened, qualified participants who are ready for site evaluation, moving studies from approval to active screening in under 24 hours. Built on Salesforce Health Cloud and fully HIPAA and GDPR compliant, TrialWire operates globally with offices in San Francisco, Sydney, Singapore and Paris. Learn more at www.trial-wire.com.

Media Contact
TrialWire PR Team
Team@trial-wire.com
www.trial-wire.com